Detalles de la búsqueda
1.
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Cardiol J;
29(4): 601-609, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621092
2.
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study.
Cardiol J;
29(6): 936-947, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200548
3.
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.
Eur Heart J Cardiovasc Pharmacother;
9(1): 38-46, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36318457
Resultados
1 -
3
de 3
1
Próxima >
>>